Collins James J. 4
4 · Senti Biosciences, Inc. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Collins James J.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-16+62,500→ 62,500 totalExercise: $0.99Exp: 2033-06-15→ Common Stock (62,500 underlying)
Footnotes (1)
- [F1]100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2024 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date.